Full-Time

Regulatory Affairs Engineer

PMS Program Management

Confirmed live in the last 24 hours

Elekta

Elekta

1,001-5,000 employees

Develops precision radiation therapy equipment and software

No salary listed

Mid

Company Does Not Provide H1B Sponsorship

Crawley, UK

Hybrid work option (you are required to work on location at least 3 days a week)

Category
Risk & Compliance
Legal & Compliance
Requirements
  • Experience in medical devices and/or Elekta products preferred.
  • Experience in regulatory affairs within the medical devices industry preferred.
  • Strong knowledge of Medical Device Regulatory Affairs and compliance requirements.
  • Proven ability to work independently and collaboratively in a regulated environment.
  • Experience in project management within regulatory affairs is a plus.
  • Ability to influence stakeholders and drive results through structured problem-solving.
  • Excellent written and verbal communication skills in English.
  • High level of personal integrity and ethics in handling regulatory matters.
  • Strong proficiency in Microsoft Office and other relevant software applications.
  • Comfortable working in a multi-cultural environment with the ability to adapt to different regulatory approaches.
  • Must be able to travel (around 10%) as required for audits and regulatory meetings.
Responsibilities
  • Participate in Post Market Surveillance (PMS) Product Report activities with cross-functional teams to ensure compliance and accuracy.
  • Manage the development of Product PMS Plans and Reports (e.g., Post Market Surveillance Report, Periodic Safety Update Report) in accordance with regulatory schedules.
  • Serve as a subject matter expert (SME) in PMS Product Report processes, providing guidance and expertise to stakeholders.
  • Support internal and external audits by providing necessary information, documentation and insights into PMS activities.
  • Maintain procedures, work instructions, and training materials for PMS Product Report program management.
  • Coordinate with the PMS Department and subject matter experts (SMEs) to align objectives and timelines.
  • Assist in the development of data collection systems to facilitate PMS Product reporting.
  • Conduct trend and competitor analysis to support PMS initiatives.
  • Ensure proper records management for PMS activities and documentation.
  • Respond to external requests for information regarding PMS activities and regulatory compliance.
  • Continuously seek and implement process improvements to enhance PMS program efficiency.
  • Escalate risks and issues to management and represent PMS in internal and external discussions.
Desired Qualifications
  • 2 years of experience in medical devices and/or Elekta products preferred.
  • 2 years of experience in regulatory affairs within the medical devices industry preferred.

Elekta focuses on precision radiation medicine, providing advanced technologies for the treatment of cancer and brain disorders. The company develops and distributes radiation therapy equipment and software solutions that help clinicians improve patient outcomes and streamline their clinical workflows. Elekta generates revenue through the sale of these medical devices and related services, catering to a wide range of clients including hospitals and cancer treatment centers. What sets Elekta apart from its competitors is its commitment to expanding access to radiation therapy in underserved markets and its emphasis on sustainability. The company's goal is to grow its global installed base of machines while enhancing the quality of care for patients.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Stockholms kommun, Sweden

Founded

1972

Simplify Jobs

Simplify's Take

What believers are saying

  • Elekta's AI-powered CT-Linac enhances adaptive radiation therapy capabilities.
  • Partnerships with Azra AI and GE Healthcare expand Elekta's oncology software solutions.
  • Acquisition of Philips' patent portfolio strengthens Elekta's treatment planning offerings.

What critics are saying

  • Increased competition from Varian Medical Systems in radiation therapy.
  • Potential supply chain disruptions due to geopolitical tensions affecting semiconductor availability.
  • Regulatory scrutiny on AI-powered medical devices could delay Elekta's technology deployment.

What makes Elekta unique

  • Elekta specializes in precision radiation medicine for cancer and brain disorders.
  • The company offers advanced radiation therapy equipment and software solutions globally.
  • Elekta emphasizes sustainability and shareholder value in its business model.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Company Match

Paid Vacation

Hybrid Work Options

Wellness Program

Tuition Reimbursement

Company News

Healthcare Journal of Baton Rouge
Apr 3rd, 2025
Mary Bird Perkins Cancer Center Expands Relationship with Elekta

Earlier this month, Mary Bird Perkins hosted Elekta's North America Elekta Unity Users Meeting.

Azra AI
Apr 3rd, 2025
Elekta and Azra AI Announce Partnership to Enhance Cancer Registry Operations with AI-Powered Automation

SAN JOSE, Calif., - Elekta (EKTA-B.ST) announced today that it has partnered with Azra AI, the industry's only end-to-end oncology workflow automation platform, to enhance cancer registry operations through automation and AI-powered data management.

Biz New Orleans
Mar 31st, 2025
Regional Cancer Center Enhances Care with Global Technology Leader

Mary Bird Perkins has partnered with Elekta for years, introducing many leading-edge technologies to ensure that patients have access to the best cancer care possible.

PharmaTimes
Mar 19th, 2025
Elekta has appointed Jonas Bolander as Acting President and CEO

Elekta has announcement the appointment of Jonas Bolander as Acting President and Chief Executive Officer (CEO).

ITN Online
May 14th, 2024
Elekta Launches AI-powered, Adaptive CT-Linac for Next Level Cancer Care

May 14, 2024 - Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments.